Fortress Biotech, Inc.
FBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$120,855 | -$154,154 | -$213,913 | -$164,826 |
| Dep. & Amort. | $4,464 | $5,997 | $9,353 | $6,791 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $32,619 | $17,029 | $22,987 | $19,486 |
| Change in WC | -$8,127 | -$12,519 | -$715 | $36,373 |
| Other Non-Cash | $11,708 | $15,422 | $2,887 | -$14,364 |
| Operating Cash Flow | -$80,191 | -$128,225 | -$179,401 | -$116,540 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15,000 | -$63 | -$2,715 | -$4,566 |
| Net Acquisitions | $0 | $0 | -$20,000 | $56,860 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$2,040 | -$213 | -$11,780 |
| Investing Cash Flow | -$15,000 | -$2,103 | -$22,928 | $40,514 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7,330 | -$38,794 | $49,248 | -$9,638 |
| Stock Issued | $82,844 | $80,376 | $40,258 | $155,255 |
| Stock Repurch. | $0 | $0 | -$1,111 | $0 |
| Dividends Paid | -$4,710 | -$8,768 | -$8,780 | -$8,780 |
| Other Fin. Act. | -$163 | -$75 | -$4,296 | $12,157 |
| Financing Cash Flow | $70,641 | $32,739 | $75,319 | $148,994 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$24,550 | -$97,589 | -$127,010 | $72,968 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $83,365 | $180,954 | $307,964 | $234,996 |
| End Cash | $58,815 | $83,365 | $180,954 | $307,964 |
| Free Cash Flow | -$95,191 | -$136,323 | -$182,456 | -$132,886 |